Sort By Category

All

Latest News

Anteris AGM 15 July 21

The Annual General Meeting of Anteris Technologies Ltd was held at 10:00 a.m. AEST on Thursday 15 July 2021.

14th Jul 2021

Anteris Technologies 'sitting on a significantly large opportunity' as it moves into FDA studies

Anteris Technologies 'sitting on a significantly large opportunity' as it moves into FDA studies

14th Jul 2021

Wayne Paterson from Anteris - Switzer Virtual Investor Day 2021

Recording of Anteris Presenting at the Switzer Small and Micro-Cap Virtual Investor Day

30th Jun 2021

MST Access Australian Micro & Small Caps Conference 2021 - Anteris Technologies Limited

Anteris Technologies Ltd's (ASX:AVR) Wayne Paterson, CEO, presented at MST Access Micro & Small Caps Conference on Thursday, 17 June

17th Jun 2021

Anteris Technologies CEO - Fortem Wealth - Quarterly Interview

CEO W. Paterson interviewed by Jacob Pritchard

1st Jun 2021

MST Access - AVR Update Report May 21

Raising DurAVR valve's clinical profile

25th May 2021

Heart Innovator Anteris Takes on Medical Device Giants

It has been a rocky corporate journey for the ASX-listed Anteris Technologies, but with its revolutionary heart technology Anteris has the ticker to be the next Aussie medical device giant.

24th May 2021

Next Generation TAVR device will enable Lifetime management of Aortic Stenosis patients - EuroPCR 2021

Next Generation TAVR device will enable Lifetime management of Aortic Stenosis patients

20th May 2021

Bioshares - Anteris Meets Catheter Milestone

Anteris Technologies Meets Catheter Milestone

3rd May 2021

Eureka Report - How Anteris Technologies got its credibility back

CEO Wayne Paterson (Anteris Technologies) is interviewed by Alan Kohler, Editor-in-Chief at Eureka Report

11th Apr 2021

Q&A with StockPal - Anteris Technologies (ASX:AVR)

CEO W. Paterson interviewed by J. Sim, Editor-in-Chief & Co-Founder at StockPal.

8th Apr 2021

Bioshares - Anteris Demonstrates ADAPT Process Outperforms Medtronic's AOA Process in Animal Study

Bioshares - Anteris Demonstrates ADAPT Process Outperforms Medtronic's AOA Process in Animal Study

6th Apr 2021